Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Debt to Equity (2022 - 2026)

HeartSciences' Debt to Equity history spans 4 years, with the latest figure at $0.16 for Q1 2026.

  • For Q1 2026, Debt to Equity changed N/A year-over-year to $0.16; the TTM value through Jan 2026 reached $0.16, changed N/A, while the annual FY2023 figure was $2.17, 395.67% up from the prior year.
  • Debt to Equity reached $0.16 in Q1 2026 per HSCS's latest filing, up from $0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $2.17 in Q2 2023 to a low of -$3.88 in Q1 2023.
  • Average Debt to Equity over 4 years is -$0.35, with a median of $0.05 recorded in 2024.
  • The largest YoY upside for Debt to Equity was 395.67% in 2023 against a maximum downside of 377.78% in 2023.
  • A 4-year view of Debt to Equity shows it stood at $0.35 in 2022, then tumbled by 377.78% to -$0.96 in 2023, then skyrocketed by 101.28% to $0.01 in 2024, then surged by 1190.62% to $0.16 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Debt to Equity are $0.16 (Q1 2026), $0.01 (Q4 2024), and $0.08 (Q3 2024).